Position in EYPT
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,291,858
-$1,398,834 QoQ
Shares Held
255,381
-0.5% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 82.95840332679408.ToString("F0")%
Shared 0.ToString("F0")%
None 17.041596673205916.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. EYPT ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in EYPT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,291,858 | 255,381 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,690,692 | 256,743 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,017,410 | 211,897 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,954,472 | 207,702 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,100,008 | 202,954 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,521,735 | 204,260 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,335,973 | 167,206 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,782,559 | 204,892 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,193,595 | 154,504 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $2,995,284 | 129,610 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $924,361 | 115,690 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $899,413 | 103,381 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $211,266 | 71,860 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $280,167 | 80,048 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $611,575 | 77,317 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $550,339 | 69,929 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $964,794 | 79,407 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $923,164 | 75,422 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $747,467 | 71,734 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $529,967 | 58,951 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||